Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QS Initiative Gains Significance In 2003 Budget Crunch – McClellan

This article was originally published in The Gray Sheet

Executive Summary

FDA's quality systems improvement initiative is the vehicle by which Commissioner Mark McClellan hopes to leverage substantial device review reforms from CDRH's FY 2003 appropriation of $208 mil

You may also be interested in...



PMA Slowdown To Persist In ’04, McClellan Says; User Fee Hikes To Follow?

FDA expects the rate of new product applications to continue declining for the foreseeable future, despite a series of review cycle improvement initiatives begun in January

PMA Slowdown To Persist In ’04, McClellan Says; User Fee Hikes To Follow?

FDA expects the rate of new product applications to continue declining for the foreseeable future, despite a series of review cycle improvement initiatives begun in January

IVD Reps Propose Alternative 510(k) Route For In Vitro Analytical Tests

An IVD industry proposal to foster a new 510(k) mechanism for innovative analyte test kits would offer a timely alternative to "homebrew" diagnostic tests

Related Content

UsernamePublicRestriction

Register

LL1135495

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel